Abstract
Psychiatry is increasingly combining new pharmacogenomic findings with therapeutic drug monitoring (TDM) to improve the safety and efficacy of pharmacotherapy. However, a distinction should be made between "nice to know" and "need to know" pharmacogenomic data because many results are statistically significant in meta-analyses but are not clinically relevant due to their low effect sizes. Some examples will illustrate this integration.
Original language | English |
---|---|
Pages (from-to) | 254-257 |
Number of pages | 4 |
Journal | Clinical Pharmacology and Therapeutics |
Volume | 95 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2014 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)